Dr. Sharron Spicer MD
Dr. Sharron Spicer is a pediatrician who has worked in community and acute care settings for 20 years. After completing medical school and residency training in Calgary, she worked as a general pediatrician in Calgary, Red Deer and Lethbridge. She led the development of the Pediatric Hospitalist program at Alberta Children’s Hospital (ACH). She completed further training in palliative care and was recruited in 2004 by the ACH Department of Pediatrics as the inaugural Section Chief of Pediatric Palliative Care. During her five-year term as Section Chief, Dr. Spicer was instrumental in the design, operational planning and opening of Rotary Flames House - Alberta’s only pediatric hospice. Dr. Spicer left the Section of Palliative Medicine in 2016 but remains a member of the ACH Department of Pediatrics with clinical roles caring for children with complex medical and mental health conditions.
Dr. Spicer has been the Physician Lead for Safety at ACH for the past five years and has served on the hospital’s Ethics Committee. She has collaborated extensively in the development of site, zone and provincial quality and safety initiatives such as Advance Care Planning, Care after Death, Medical Assistance in Dying and Solutions for Patient Safety.
Dr. Spicer received the Canadian Certified Physician Executive credential from the Canadian Society of Physician Leaders in 2017. She is the Past President of the Calgary and Area Medical Staff Society. She serves on the editorial boards of Vital Signs and the Canadian Journal of Physician Leadership.
She joined the Alberta Medical Association’s Physician and Family Support Program as an assessment physician in 2016 and has been an invited speaker at wellness seminars for residents and physicians around Alberta.
Dr. Spicer loves getting out to the mountains, so she is delighted for the invitation to speak to you about physician wellness.
I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose.
I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).